ASX - By Stock
|
TLX |
Re:
Telix in China
|
|
Compounder50
|
64 |
25K |
2 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
64
|
25K
|
2
|
|
ASX - By Stock
|
TLX |
Telix in China
|
|
Compounder50
|
64 |
25K |
8 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
64
|
25K
|
8
|
|
ASX - By Stock
|
TLX |
Re:
Radiopharm - anyone know how this compares to TLX?
|
|
Compounder50
|
44 |
21K |
8 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
44
|
21K
|
8
|
|
Charts
|
TLX |
Re:
2022 CHART THREAD
|
|
Compounder50
|
338 |
111K |
6 |
28/07/22 |
28/07/22 |
Charts
|
338
|
111K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
Jarden valuation
|
|
Compounder50
|
38 |
20K |
5 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
38
|
20K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Jarden valuation
|
|
Compounder50
|
38 |
20K |
2 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
38
|
20K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
Compounder50
|
119 |
32K |
1 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
119
|
32K
|
1
|
|
Charts
|
TLX |
Re:
2022 CHART THREAD
|
|
Compounder50
|
338 |
111K |
1 |
18/07/22 |
18/07/22 |
Charts
|
338
|
111K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
US Insurance companies denying coverage for Illucix
|
|
Compounder50
|
22 |
6.9K |
3 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
22
|
6.9K
|
3
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Take Over offer
|
|
Compounder50
|
24 |
11K |
2 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
24
|
11K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Take Over offer
|
|
Compounder50
|
24 |
11K |
2 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
24
|
11K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Jubilant Radiopharma Joins Illuccix® Pharmacy Partner Network
|
|
Compounder50
|
6 |
2.1K |
2 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
6
|
2.1K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Expansion of Partnership with RefleXion for Prostate Cancer
|
|
Compounder50
|
14 |
5.9K |
9 |
10/06/22 |
10/06/22 |
ASX - By Stock
|
14
|
5.9K
|
9
|
|
ASX - By Stock
|
TLX |
Re:
News: TLX Telix Pharmaceuticals Says Doug Cubbin Will Step Down As Group CFO
|
|
Compounder50
|
7 |
2.5K |
9 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
7
|
2.5K
|
9
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Chairman's Address to Annual General Meeting
|
|
Compounder50
|
23 |
6.2K |
4 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
23
|
6.2K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Cancellation of Share Purchase Plan
|
|
Compounder50
|
23 |
10K |
2 |
17/05/22 |
17/05/22 |
ASX - By Stock
|
23
|
10K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Shorters discover Telix
|
|
Compounder50
|
234 |
85K |
6 |
06/05/22 |
06/05/22 |
ASX - By Stock
|
234
|
85K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
Approval
|
|
Compounder50
|
48 |
18K |
11 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
48
|
18K
|
11
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for March 2022 quarter
|
|
Compounder50
|
13 |
4.3K |
4 |
22/04/22 |
22/04/22 |
ASX - By Stock
|
13
|
4.3K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for March 2022 quarter
|
|
Compounder50
|
13 |
4.3K |
5 |
22/04/22 |
22/04/22 |
ASX - By Stock
|
13
|
4.3K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
My analysis and intrinsic value of TLX March 2022
|
|
Compounder50
|
82 |
43K |
16 |
28/03/22 |
28/03/22 |
ASX - By Stock
|
82
|
43K
|
16
|
|
ASX - By Stock
|
TLX |
Re:
My analysis and intrinsic value of TLX March 2022
|
|
Compounder50
|
82 |
43K |
4 |
28/03/22 |
28/03/22 |
ASX - By Stock
|
82
|
43K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
How low will it go?
|
|
Compounder50
|
132 |
60K |
4 |
13/02/22 |
13/02/22 |
ASX - By Stock
|
132
|
60K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Despatch of SPP Booklet to Eligible Shareholders
|
|
Compounder50
|
15 |
4.8K |
3 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
15
|
4.8K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Despatch of SPP Booklet to Eligible Shareholders
|
|
Compounder50
|
15 |
4.8K |
6 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
15
|
4.8K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
How low will it go?
|
|
Compounder50
|
132 |
60K |
11 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
132
|
60K
|
11
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Trading Halt
|
|
Compounder50
|
36 |
16K |
8 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
36
|
16K
|
8
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Investor Presentation to JP Morgan Healthcare Conference
|
|
Compounder50
|
8 |
4.3K |
10 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
8
|
4.3K
|
10
|
|
ASX - By Stock
|
RAD |
Re:
RAD Chart
|
|
Compounder50
|
87 |
26K |
1 |
10/01/22 |
10/01/22 |
ASX - By Stock
|
87
|
26K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: FDA Approves Telix Prostate Cancer Imaging Product Illuccix
|
|
Compounder50
|
42 |
16K |
8 |
04/01/22 |
04/01/22 |
ASX - By Stock
|
42
|
16K
|
8
|
|
ASX - By Stock
|
TLX |
Re:
Interesting interview with CEO
|
|
Compounder50
|
6 |
3.9K |
9 |
23/12/21 |
23/12/21 |
ASX - By Stock
|
6
|
3.9K
|
9
|
|
ASX - By Stock
|
TLX |
Re:
Radiopharm - anyone know how this compares to TLX?
|
|
Compounder50
|
44 |
21K |
9 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
44
|
21K
|
9
|
|
ASX - By Stock
|
TLX |
Re:
Radiopharm - anyone know how this compares to TLX?
|
|
Compounder50
|
44 |
21K |
3 |
13/12/21 |
13/12/21 |
ASX - By Stock
|
44
|
21K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Radiopharm - anyone know how this compares to TLX?
|
|
Compounder50
|
44 |
21K |
9 |
12/12/21 |
12/12/21 |
ASX - By Stock
|
44
|
21K
|
9
|
|
ASX - By Stock
|
TLX |
Re:
Radiopharm - anyone know how this compares to TLX?
|
|
Compounder50
|
44 |
21K |
2 |
12/12/21 |
12/12/21 |
ASX - By Stock
|
44
|
21K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Radiopharm - anyone know how this compares to TLX?
|
|
Compounder50
|
44 |
21K |
6 |
11/12/21 |
11/12/21 |
ASX - By Stock
|
44
|
21K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
Wilsons Advisory - Healthcare 2022 Top Six - TLX New price target of $10.35 per share (Overweight)
|
|
Compounder50
|
4 |
2.4K |
7 |
09/12/21 |
09/12/21 |
ASX - By Stock
|
4
|
2.4K
|
7
|
|
ASX - By Stock
|
RAD |
Re:
RAD Chart
|
|
Compounder50
|
87 |
26K |
1 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
87
|
26K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Illuccix Granted Use Authorisation in Brazil
|
|
Compounder50
|
44 |
18K |
3 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
44
|
18K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Radiopharm - anyone know how this compares to TLX?
|
|
Compounder50
|
44 |
21K |
3 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
44
|
21K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Radiopharm - anyone know how this compares to TLX?
|
|
Compounder50
|
44 |
21K |
3 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
44
|
21K
|
3
|
|
ASX - By Stock
|
RAD |
Value in RAD
|
|
Compounder50
|
2 |
1.4K |
17 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
2
|
1.4K
|
17
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Illuccix Granted Use Authorisation in Brazil
|
|
Compounder50
|
44 |
18K |
9 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
44
|
18K
|
9
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Investor Presentation - November 2021
|
|
Compounder50
|
7 |
4.4K |
17 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
7
|
4.4K
|
17
|
|
ASX - By Stock
|
TLX Biotech |
Re:
TLX FDA Approval Pending Rocketship.
|
|
Compounder50
|
70 |
48K |
9 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
70
|
48K
|
9
|
|
ASX - By Stock
|
TLX |
Re:
Approval
|
|
Compounder50
|
48 |
18K |
8 |
09/11/21 |
09/11/21 |
ASX - By Stock
|
48
|
18K
|
8
|
|
ASX - By Stock
|
TLX |
Re:
Jarden valuation
|
|
Compounder50
|
38 |
20K |
6 |
05/11/21 |
05/11/21 |
ASX - By Stock
|
38
|
20K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
Jarden valuation
|
|
Compounder50
|
38 |
20K |
14 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
38
|
20K
|
14
|
|
ASX - By Stock
|
TLX |
Re:
Jarden valuation
|
|
Compounder50
|
38 |
20K |
6 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
38
|
20K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Australian TGA Approves Illuccix for Prostate Cancer Imaging
|
|
Compounder50
|
31 |
13K |
11 |
02/11/21 |
02/11/21 |
ASX - By Stock
|
31
|
13K
|
11
|
|